What is the share price of ANG Lifesciences India Ltd (ANG) today?
The share price of ANG as on 9th July 2025 is ₹33.91. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on ANG Lifesciences India Ltd (ANG) share?
The past returns of ANG Lifesciences India Ltd (ANG) share are- Past 1 week: 14.83%
- Past 1 month: 13.36%
- Past 3 months: 19.89%
- Past 6 months: -20.95%
- Past 1 year: -33.13%
- Past 3 years: -81.00%
- Past 5 years: 145.39%
What are the peers or stocks similar to ANG Lifesciences India Ltd (ANG)?
The peers or stocks similar to ANG Lifesciences India Ltd (ANG) include:What is the market cap of ANG Lifesciences India Ltd (ANG) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of ANG Lifesciences India Ltd (ANG) is ₹45.18 Cr as of 9th July 2025.What is the 52 week high and low of ANG Lifesciences India Ltd (ANG) share?
The 52-week high of ANG Lifesciences India Ltd (ANG) is ₹62.75 and the 52-week low is ₹21.03.What is the PE and PB ratio of ANG Lifesciences India Ltd (ANG) stock?
The P/E (price-to-earnings) ratio of ANG Lifesciences India Ltd (ANG) is -3.64. The P/B (price-to-book) ratio is 0.59.Which sector does ANG Lifesciences India Ltd (ANG) belong to?
ANG Lifesciences India Ltd (ANG) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy ANG Lifesciences India Ltd (ANG) shares?
You can directly buy ANG Lifesciences India Ltd (ANG) shares on Tickertape. Simply sign up, connect your demat account and place your order.
ANG Lifesciences India Ltd
ANG Share Price
33.911.99% (-0.69)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ANG Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
BadThe stock is in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
ANG Performance & Key Metrics
ANG Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -3.64 | 0.59 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.69 | 6.41 | 0.79% |
ANG Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ANG Company Profile
ANG Lifesciences India is a pharmaceutical company, engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials
SUNPHARMA
PE Ratio
36.72
36.72
1Y Return
7.46%
7.46%
Buy Reco %
87.50
87.50
CIPLA
PE Ratio
22.80
22.80
1Y Return
0.08%
0.08%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
58.83
58.83
1Y Return
15.25%
15.25%
Buy Reco %
70.83
70.83
DRREDDY
PE Ratio
18.89
18.89
1Y Return
1.76%
1.76%
Buy Reco %
55.17
55.17
MANKIND
PE Ratio
50.40
50.40
1Y Return
17.92%
17.92%
Buy Reco %
81.25
81.25
ANG Forecast
ANG Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ANG
ANG
Income
Balance Sheet
Cash Flow
Annual Normal View
ANG Income Statement
ANG Income Statement
Annual Normal View
| Financial Year | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 154.93 | 355.20 | 229.61 | 146.81 | 94.86 | 94.85 | ||||||
Raw Materials | 140.12 | 234.65 | 156.08 | 102.79 | 95.11 | 95.12 | ||||||
| Power & Fuel Cost | 6.14 | 6.50 | 4.15 | |||||||||
| Employee Cost | 21.29 | 23.97 | 19.35 | |||||||||
| Selling & Administrative Expenses | 18.70 | 15.49 | 12.85 | |||||||||
| Operating & Other expenses | 5.62 | 3.12 | -1.39 | |||||||||
EBITDA | 14.81 | 68.80 | 24.45 | 9.06 | -0.25 | -0.27 | ||||||
| Depreciation/Amortization | 1.33 | 5.88 | 9.35 | 8.37 | 6.76 | 6.75 | ||||||
| PBIT | 13.48 | 62.92 | 15.10 | 0.69 | -7.01 | -7.02 | ||||||
| Interest & Other Items | 3.52 | 9.42 | 12.48 | 11.41 | 8.69 | 8.68 | ||||||
| PBT | 9.96 | 53.50 | 2.62 | -10.72 | -15.70 | -15.70 | ||||||
| Taxes & Other Items | 3.11 | 13.19 | 2.89 | -0.57 | -3.29 | -3.29 | ||||||
| Net Income | 6.85 | 40.31 | -0.27 | -10.15 | -12.41 | -12.41 | ||||||
| EPS | 4.74 | 31.11 | -0.21 | -7.77 | -9.42 | -9.50 | ||||||
| DPS | — | 0.80 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Payout ratio | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
ANG Company Updates
ANG Stock Peers
ANG Past Performance & Peer Comparison
ANG Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| ANG Lifesciences India Ltd | -3.64 | 0.59 | — |
| Sun Pharmaceutical Industries Ltd | 36.72 | 5.54 | 0.96% |
| Cipla Ltd | 22.80 | 3.84 | 1.07% |
| Torrent Pharmaceuticals Ltd | 58.83 | 14.81 | 0.18% |
ANG Stock Price Comparison
Compare ANG with any stock or ETFCompare ANG with any stock or ETF
ANG
ANG Holdings
ANG Shareholdings
ANG Promoter Holdings Trend
ANG Promoter Holdings Trend
ANG Institutional Holdings Trend
ANG Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ANG Shareholding Pattern
ANG Shareholding Pattern
ANG Shareholding History
ANG Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ANG stock
smallcases containing ANG stock
Looks like this stock is not in any smallcase yet.
ANG Events
ANG Events
ANG Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ANG Dividend Trend
No dividend trend available
ANG Upcoming Dividends
ANG Upcoming Dividends
No upcoming dividends are available
ANG Past Dividends
ANG Past Dividends
Cash Dividend
Ex DateEx DateNov 2, 2021
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Nov 2, 2021
ANG Stock News & Opinions
ANG Stock News & Opinions
Articles & Videos
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 2.06 crore in the March 2025 quarter
Net Loss of ANG Lifesciences India reported to Rs 2.06 crore in the quarter ended March 2025 as against net loss of Rs 3.65 crore during the previous quarter ended March 2024. Sales declined 55.55% to Rs 16.82 crore in the quarter ended March 2025 as against Rs 37.84 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 12.41 crore in the year ended March 2025 as against net loss of Rs 10.14 crore during the previous year ended March 2024. Sales declined 36.45% to Rs 92.85 crore in the year ended March 2025 as against Rs 146.11 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales16.8237.84 -56 92.85146.11 -36 OPM %-4.168.88 --2.446.61 - PBDT-2.47-0.29 -752 -8.94-0.60 -1390 PBT-3.89-2.34 -66 -15.70-8.97 -75 NP-2.06-3.65 44 -12.41-10.14 -22 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
ANG Lifesciences India to hold board meeting
ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
ANG Lifesciences India Ltd leads losers in 'B' group
Adroit Infotech Ltd, Dynamic Cables Ltd, Archidply Decor Ltd and Kwality Pharmaceuticals Ltd are among the other losers in the BSE's 'B' group today, 20 March 2025.ANG Lifesciences India Ltd crashed 9.96% to Rs 26.57 at 14:33 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 94016 shares were traded on the counter so far as against the average daily volumes of 13382 shares in the past one month.Adroit Infotech Ltd tumbled 7.84% to Rs 13.64. The stock was the second biggest loser in 'B' group.On the BSE, 76506 shares were traded on the counter so far as against the average daily volumes of 5344 shares in the past one month.Dynamic Cables Ltd lost 7.42% to Rs 533.5. The stock was the third biggest loser in 'B' group.On the BSE, 30414 shares were traded on the counter so far as against the average daily volumes of 8951 shares in the past one month.Archidply Decor Ltd shed 7.31% to Rs 68.5. The stock was the fourth biggest loser in 'B' group.On the BSE, 112 shares were traded on the counter so far as against the average daily volumes of 238 shares in the past one month.Kwality Pharmaceuticals Ltd corrected 6.90% to Rs 652. The stock was the fifth biggest loser in 'B' group.On the BSE, 24717 shares were traded on the counter so far as against the average daily volumes of 14355 shares in the past one month.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 5.19 crore in the December 2024 quarter
Net Loss of ANG Lifesciences India reported to Rs 5.19 crore in the quarter ended December 2024 as against net loss of Rs 5.93 crore during the previous quarter ended December 2023. Sales rose 33.32% to Rs 24.73 crore in the quarter ended December 2024 as against Rs 18.55 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales24.7318.55 33 OPM %-8.69-10.30 - PBDT-4.42-4.45 1 PBT-6.38-6.37 0 NP-5.19-5.93 12 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
ANG Lifesciences India schedules board meeting
ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 2.09 crore in the September 2024 quarter
Net Loss of ANG Lifesciences India reported to Rs 2.09 crore in the quarter ended September 2024 as against net loss of Rs 2.32 crore during the previous quarter ended September 2023. Sales declined 1.14% to Rs 32.88 crore in the quarter ended September 2024 as against Rs 33.26 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales32.8833.26 -1 OPM %6.964.99 - PBDT0.45-0.41 LP PBT-1.29-2.63 51 NP-2.09-2.32 10 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
ANG Lifesciences India to conduct board meeting
ANG Lifesciences India will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
ANG Lifesciences India to hold AGM
ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
ANG Lifesciences India to convene AGM
ANG Lifesciences India announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
ANG Lifesciences India reports consolidated net loss of Rs 3.07 crore in the June 2024 quarter
Net loss of ANG Lifesciences India reported to Rs 3.07 crore in the quarter ended June 2024 as against net profit of Rs 1.75 crore during the previous quarter ended June 2023. Sales declined 67.39% to Rs 18.41 crore in the quarter ended June 2024 as against Rs 56.46 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales18.4156.46 -67 OPM %-9.2311.58 - PBDT-2.514.55 PL PBT-4.142.36 PL NP-3.071.75 PL Powered by Capital Market - Live
10 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
A significant proportion of promoter holdings is pledged